Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
TNF Pharmaceuticals ( (TNFA) ) just unveiled an update.
On September 22, 2025, TNF Pharmaceuticals officially changed its name to Q/C Technologies, reflecting its strategic shift towards quantum-class computing. The company’s stock began trading under the new ticker symbol ‘QCLS’ on the Nasdaq Stock Market on September 25, 2025. This transition aligns with Q/C Technologies’ focus on photonic computing and its exclusive rights to LightSolver’s platform, aiming to enhance its market position and shareholder value.
More about TNF Pharmaceuticals
Q/C Technologies, formerly known as TNF Pharmaceuticals, operates in the high-performance computing industry with a focus on quantum-class computing. The company holds exclusive global rights to LightSolver’s light-speed laser processing unit, which is used for quantum-class cryptocurrency applications, positioning it at the forefront of this innovative computing paradigm.
Average Trading Volume: 1,611,301
Technical Sentiment Signal: Strong Sell
Current Market Cap: $9.29M
See more insights into TNFA stock on TipRanks’ Stock Analysis page.